Noncompliance Issues In Mexico Lead To Decreased Growth For Herbalife
This article was originally published in The Tan Sheet
Executive Summary
Herbalife announces Jan. 4 it lowered its 2007 sales growth expectations because of problems in Mexico, including noncompliance issues
You may also be interested in...
Herbalife Q3
Net sales for the third quarter were up 18.8% over the prior-year period to $476.4 mil., largely attributable to revenue increases in the U.S. (up 24.7%) and Mexico (up 66%), Herbalife announces Nov. 8. New products launched during the quarter included a water-mixable version of the Formula 1 protein drink and a reformulated version of the Garden 7 phytonutrient supplement. The firm opened five stores in China, bringing its presence in that country to 33 stores in 20 provinces. Greater China accounted for 7.6% of worldwide sales, contributing $36.2 mil. during the quarter. The company expects net sales growth of 18%-20% during the fourth quarter...
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers